Role of OATP1B1 and Its Polymorphisms in Ticagrelor Hepatic Disposition and Platelet Response

Trial Profile

Role of OATP1B1 and Its Polymorphisms in Ticagrelor Hepatic Disposition and Platelet Response

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 17 Apr 2018

At a glance

  • Drugs Ticagrelor (Primary)
  • Indications Abdominal aortic aneurysm; Acute coronary syndromes; Cardiovascular disorders; Community-acquired pneumonia; Coronary artery disease; Sickle cell anaemia; Stroke
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 17 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top